JP
TNDM icon

John Paulson’s Tandem Diabetes Care TNDM Stock Holding History

John Paulson’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-50,000
Closed -$400K – 87
2017
Q2 		$400K Hold
50,000
– – 0.01% 106
2017
Q1 		$600K Buy
+50,000
New +$1.09M 0.01% 93

Other funds holding TNDM

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

John Paulson's TNDM Position: Q3 2017 in Review

John Paulson sold out of Tandem Diabetes Care (TNDM) in Q3 2017, closing a stake of 50,000 shares — an estimated $400K sold.

John Paulson first reported a position in TNDM in Q1 2017 and held it in 2 quarters. The position peaked at $600K in Q1 2017. 46 funds tracked by Wall St. Rank hold TNDM as of Q3 2017.

  • John Paulson reported no remaining Tandem Diabetes Care position as of Q3 2017 after selling out during the quarter.
  • John Paulson sold 50,000 Tandem Diabetes Care shares in Q3 2017, an estimated $400K.
  • John Paulson first reported a position in Tandem Diabetes Care in Q1 2017 and held it in 2 quarters.
  • John Paulson's Tandem Diabetes Care position peaked at $600K in Q1 2017.
  • 46 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2017.

Based on Paulson & Co's 13F filing for Q3 2017, filed 14 Nov 2017.